# rs4784227 and Breast cancer (16q12)

Configuration `single`, named mode, seed 0. Models: generator deepseek/deepseek-v4.1-flash-1017, critic deepseek/deepseek-v4.1-flash-1017, summariser deepseek/deepseek-v4.1-flash-1017. Cost $0.00 over 2 model calls; 40 s.

Variant `chr16:52565276:C>T` (germline); expression context: DepMap:ACH-000019 (MCF7).

## Ranked chains

### 1. C1: C1: T allele creates a stronger FOXA1 enhancer site that increases TOX3 expression. (p = 0.42)

TF FOXA1 (stated coverage not_checked; registry own_model), alt allele binds more; element putative TOX3 enhancer; gene TOX3; cell type MCF7 luminal breast epithelial.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | FOXA1 binds the T allele of rs4784227 more strongly than the C allele; QBiC-SELEX coverage is not_checked because no QBiC-SELEX evidence was supplied. | missing | none |
| element | rs4784227 lies in a putative TOX3 enhancer in 16q12 that is active in breast epithelial cells. | missing | none |
| gene | This enhancer regulates TOX3, the nearest 16q12 breast-cancer-associated gene. | missing | none |
| cell_type | The mechanism operates in MCF7-like luminal breast epithelial cells. | missing | none |
| phenotype | T-allele-driven increased TOX3 expression raises breast cancer risk. | missing | none |

Predictions: T allele binds FOXA1 more strongly than C in EMSA and in allele-specific ChIP.; The variant lies in an enhancer active in luminal breast cells.; Higher FOXA1 occupancy increases TOX3 expression in MCF7-like cells.; Increased TOX3 dosage promotes breast cancer risk.

Falsified if: No allele-specific FOXA1 binding at rs4784227 is reproducible.; The element shows no rs4784227-dependent enhancer activity or TOX3 expression effect in breast cells.

### 2. C4: Null: rs4784227 has no TF-mediated allelic effect; association is via linkage or passenger mechanism. (p = 0.35)

Null chain: no TF-mediated effect of this variant.

Predictions: No reproducible allele-specific TF binding at rs4784227.; No rs4784227-dependent enhancer activity or TOX3 expression difference.; Disease association is explained by a linked causal variant or by chance/passenger effects.

Falsified if: A reproducible allele-specific TF binding and enhancer/expression effect at rs4784227 is demonstrated in breast cells.

### 3. C2: C2: T allele disrupts a FOXA1 enhancer site, lowering TOX3 expression. (p = 0.12)

TF FOXA1 (stated coverage not_checked; registry own_model), ref allele binds more; element putative TOX3 enhancer; gene TOX3; cell type MCF7 luminal breast epithelial.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | FOXA1 binds the C allele of rs4784227 more strongly than the T allele; QBiC-SELEX coverage is not_checked because no QBiC-SELEX evidence was supplied. | missing | none |
| element | rs4784227 lies in a putative TOX3 enhancer in 16q12. | missing | none |
| gene | The enhancer regulates TOX3. | missing | none |
| cell_type | The relevant cells are MCF7-like luminal breast epithelial cells. | missing | none |
| phenotype | Reduced TOX3 expression increases breast cancer risk. | missing | none |

Predictions: C allele binds FOXA1 more strongly than T in EMSA and allele-specific ChIP.; The variant lies in a TOX3 enhancer active in breast cells.; Lower FOXA1 occupancy at T decreases TOX3 expression if FOXA1 is activating.; Altered TOX3 dosage changes breast cancer risk.

Falsified if: No allele-specific FOXA1 binding with C stronger than T is reproducible.; The element shows no rs4784227-dependent TOX3 expression effect in breast cells.

### 4. C3: C3: T allele strengthens a GATA3 enhancer site and increases TOX3. (p = 0.11)

TF GATA3 (stated coverage not_checked; registry own_model), alt allele binds more; element GATA3-responsive TOX3 enhancer; gene TOX3; cell type MCF7 luminal breast epithelial.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | GATA3 binds the T allele of rs4784227 more strongly than the C allele; QBiC-SELEX coverage is not_checked because no QBiC-SELEX evidence was supplied. | missing | none |
| element | rs4784227 lies in a GATA3-responsive TOX3 enhancer in 16q12. | missing | none |
| gene | GATA3 binding at this element regulates TOX3. | missing | none |
| cell_type | The mechanism operates in MCF7-like luminal breast epithelial cells. | missing | none |
| phenotype | GATA3-driven TOX3 expression raises breast cancer risk. | missing | none |

Predictions: T allele binds GATA3 more strongly than C.; GATA3 occupancy at rs4784227 is detectable in breast cells.; GATA3 binding increases TOX3 expression in luminal breast cells.; TOX3 increase raises breast cancer risk.

Falsified if: No allele-specific GATA3 binding at rs4784227 is reproducible.; GATA3 occupancy at this element does not affect TOX3 expression in breast cells.

## Prediction matrix

| Test | Cost | Separates top two | C1 | C4 | C2 | C3 |
| --- | --- | --- | --- | --- | --- | --- |
| Allele-specific EMSA with FOXA1 protein or DNA-binding domain and C vs T probes | low | yes | T probe shifts more strongly than C | No reproducible allele-specific shift | C probe shifts more strongly than T |  |
| Allele-specific GATA3 ChIP-qPCR at rs4784227 in MCF7 cells | medium | no |  | No allele-specific GATA3 binding |  | GATA3 binding is stronger on T than C |
| Allele-specific FOXA1 ChIP-qPCR at rs4784227 in MCF7 cells | medium | yes | FOXA1 binding is stronger on T than C | No allele-specific FOXA1 binding | FOXA1 binding is stronger on C than T |  |

## Next experiment

A JSON object containing the four mechanisms likely accounting for the association between rs4784227 and 16q12 breast cancer.

## Flags

- none

## Evidence
